Difference between revisions of "Part:BBa K3166000:Experience"

Line 1: Line 1:
  
 
__NOTOC__
 
__NOTOC__
In our study, we aim to achieve squalene synthesis in E.coli, so at the beginning, We cloned YSS, NSS, KSS and thSQS.
 
 
It has been reported that dehydrosqualene desaturated CrtN from staphylococcus aureus can convert squalene into yellow carotenoids. By extracting and detecting yellow carotenoids, the activity of squalene synthase from different sources can be quickly compared, so as to screen out the highly active squalene synthase. We constructed genes YSS, NSS, KSS and thSQS on a plasmid with CrtN and co-transformed plasmids containing different squalene synthase genes and CrtN genes into BL21(DE3) with plasmid p35151 containing MVA pathway. Constructed strains were selected monoclonal and fermented in a tube for 48 hours. The bacteria were collected for acetone extraction, and the absorbance of the extracted solution was determined at 470nm with an ultraviolet spectrophotometer. Results showed that the strain containing YSS gene had the highest absorbance, so we decided to use YSS to construct the squalene synthesis pathway E. coli.
 
 
To construct squalene synthesis pathway in E. coli, the YSS gene was sub-cloned into plasmid pETDuet-1, yielding pET-YSS. Co-transformation of the resultant plasmid pET-YSS with p35151 resulted in squalene production of 18.9 mg/L.
 
 
We overexpressed idi and ispA in order to direct the metabolic flow to the squalene precursor FPP. We introduce genes idi and ispA into plasimid pET-YSS, yielding pET-IAY. Co-transformation of the plasmid pET-IAY with p35151 resulted in squalene production of 69.3 mg/L, an approximately 3.7-fold increase compared to BL21(DE3) harboring pET-YSS and p35151.
 
 
We speculated that if the supply of precursors IPP and DMAPP is increased, the squalene yield can be further increased. The MVA and MEP pathways have been the targets of many metabolic engineering efforts to increase the supply of IPP and DMAPP in host microorganisms for improved terpenoid production. We have introduced the MVA pathway into the chassis cell, and now we need to optimize the MEP pathway. It is well known that gene dxs plays an important role in enhancing IPP/DMAPP flux. It was demonstrated that balanced activation of IspG and IspH could improve isoprenoids production. We are going to overexpress the key enzymes Dxs and activate the balance of gene ispG and ispH by constructing them into different plasmids.
 
 
The gene Dxs and ispG were placed on the skeleton of low-copy plasmid pBBR1MCS-2, and the promoter was lac promoter of medium strength. The gene ispH was added to the high copy plasmid pET-IAY with a strong promoter T7. By co-transforming the two constructed plamids and p35151 into E. coli BL21 (DE3), the yield of squalene was 472.3mg /L, which was 6.8 times higher than that of the strain only overexpressing idi and ispA.
 
 
Plasmid P35151 contains 7 genes in the MVA pathway: AtoB, HMGS, tHMGR, MK, PMK, PMD and idi. These seven genes were integrated into a single operon. We attempted to divide the MVA pathway genes contained in plasmid p35151 into two parts and constructed them on pBBR1MCS-1 and pBBR1MCS-2. The constructed plasmids were as follows:
 
 
PMVA1 took plasmid pBBR1MCS-1 as the skeleton carrier, and the promoter was lac promoter of medium strength. As pBBR1MCS-1 has the same replicator as pBBR1MCS-2 does, its replicator was replaced with p15A, which contained the first three genes of MVA pathway, atoB, HMGS and tHMGR.
 
 
PMVA2 took the plasmid pBBR1MCS-2 as the skeleton carrier, its promoter was lac promoter of medium strength, its replicator was pBBR1 oriV, and it contained the four MVA pathway genes MK, PMK, PMD and idi. All 7 genes on plasmid pMVA1 and pMVA2 were derived from plasmid p35151.
 
 
Co-transformation of the plasmid pET-IAY with pMVA1 and pMVA2 resulted in squalene production of 974.3 mg/L, an approximately 52-fold increase compared to BL21(DE3) harboring pET-YSS and p35151. This level of production is 4-fold of the highest reported value (230 mg/L) for E. coli.
 
 
===Applications of BBa_K3166000===
 
===Applications of BBa_K3166000===
  

Revision as of 07:15, 20 October 2019


Applications of BBa_K3166000

User Reviews

UNIQafc46805b74e92dd-partinfo-00000000-QINU UNIQafc46805b74e92dd-partinfo-00000001-QINU